EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function


Journal of Clinical Endocrinology and Metabolism 98(3): E446-E454
RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function
Previously we identified RTN4IP1 to be differentially expressed in thyroid cancer by sex and the gene is located on chromosome 6q21, a chromosomal region frequently deleted or with loss of heterozygosity in a variety of human malignancies including thyroid cancer. Because the expression and function of this gene is unknown, we sought to characterize its expression in normal, hyperplastic, and benign and malignant thyroid tissue samples and to evaluate its function in cancer cells. RTN4IP1 expression was analyzed in normal and hyperplastic thyroid tissue and benign and malignant thyroid tissue samples. In 3 thyroid cancer cell lines (TPC1 from a papillary thyroid cancer, FTC133 from a follicular thyroid cancer, XTC1 from a Hürthle cell carcinoma), small interfering RNA knockdown of RTN4IP1 was used to determine its role in regulating the hallmarks of malignant cell phenotype (cellular proliferation, migration, apoptosis, invasion, tumor spheroid formation, anchorage independent growth). We found RTN4IP1 mRNA expression was significantly down-regulated in follicular and papillary thyroid cancer as compared with normal, hyperplastic, and benign thyroid neoplasms (P < .05). Moreover, RTN4IP1 mRNA expression was significantly lower in larger papillary thyroid cancers (P < .05). Small interfering RNA knockdown of RTN4IP1 expression increased cellular proliferation (2- to 4-fold) in all 3 of the cell lines tested and increased cellular invasion (1.5- to 3-fold) and migration (2- to 7.5-fold), colony formation (3- to 6-fold), and tumor spheroid formation (P < .05) in 2 of the 3 cell lines tested (FTC-133 and XTC1). This is the first study to characterize the expression and function of RTN4IP1 in cancer. Our results demonstrate RTN4IP1 is down-regulated in thyroid cancer and is associated with larger papillary thyroid cancer and that it regulates malignant cell phenotype. These findings, taken together, suggest that RTN4IP1 has a tumor-suppressive function and may regulate thyroid cancer progression.


Accession: 055338926

PMID: 23393170

DOI: 10.1210/jc.2012-3180



Related references

Tumour suppressive function of HUWE1 in thyroid cancer. Journal of Biosciences 41(3): 395-405, 2016

The tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule in human prostate cancer development. Journal of Urology 151(5 SUPPL ): 369A, 1994

Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer. Anticancer Research 26(6b): 4437-4442, 2007

Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer. Anticancer Research 26(6B): 4437-4442, 2006

Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells. Anticancer Research 33(11): 4921-4926, 2014

Decreased miR-452 expression in human colorectal cancer and its tumor suppressive function. Genetics and Molecular Research 15(2): -, 2016

Molecular characterization of the tumor-suppressive function of nischarin in breast cancer. Journal of the National Cancer Institute 103(20): 1513-1528, 2011

Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. Plos One 8(10): E76402-E76402, 2014

Decreased expression of miR-874 and its tumor suppressive function in human colorectal cancer. Genetics and Molecular Research 15(2): -, 2016

Stage dependent expression and tumor suppressive function of FAM134B (JK1) in colon cancer. Molecular Carcinogenesis 56(1): 238-249, 2016